Andrew W. Campbell, MD 
Mycotoxins aren’t living organisms — they’re toxic molecules that trigger antibodies capable of attaching to human tissue and setting off autoimmunity. Understanding that distinction reshapes how we test for and treat mold illness.
Toxic molds can affect the nervous system in children who are chronically exposed. Common neurological symptoms are headaches, fatigue, sleep disturbance, confusion, mood swings, nosebleeds, and cough. High levels of sensorimotor dysfunction and the related disorders in children means that toxic mold exposure should be regarded as a serious neurological health concern in children.
Why patients with chronic mold exposure can show persistent B12 deficiency despite adequate intake—and what this means for brain health.
It is an uncontested medical and scientific fact that molds and mycotoxins cause diseases in humans. Too often, they are overlooked and not part of clinicians’ differential diagnosis. Both are health hazards—molds produce metabolites such as mycotoxins and solvents, shed antigenic materials such as spores, hyphae, extracellular polysaccharides, and enzymes, which are toxic and cause immunologic responses.
Join Dr. Andrew Campbell, MD, for an evidence-based deep dive into the clinical impact of mycotoxins—secondary metabolites of toxic mold linked in the literature to neurodegenerative, autoimmune, and complex chronic conditions. In this focused webinar, Dr. Campbell will review CNS effects, blood-brain barrier penetration, demyelination, microbiome interactions, diagnostic testing strategies,Read
Mycotoxins—termed the “Great Masquerader” by the WHO—may underlie chronic inflammatory, neurologic, endocrine, and immune conditions. This clinical review outlines mechanisms, laboratory testing limitations, systemic effects, and evidence-informed treatment strategies for functional and integrative practitioners.
